<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="Commons Attribution 4.0 International license.mBio.02494-19.pdf Efficient and safe vaccines against" exact="yellow fever" post="(e.g., YFV-17D) that provide long-lasting protection by rapidly inducing"/>
 <result pre="years. Here we report that JE-CVax/Imojev, a YFV-17D-based chimeric Japanese" exact="encephalitis" post="vaccine, also efficiently protects against YFV infection in mice."/>
 <result pre="mice. In case of shortage of the YFV vaccine during" exact="yellow fever" post="outbreaks, (off-label) use of JE-CVax/Imojev may be considered. Moreover,"/>
 <result pre="vaccine candidates) could be designed. Abstract ABSTRACT Recent outbreaks of" exact="yellow fever" post="virus (YFV) in West Africa and Brazil resulted in"/>
 <result pre="report that a live attenuated virus similar to the Japanese" exact="encephalitis" post="virus (JEV) vaccine JE-CVax/Imojev that consists of YFV-17D vaccine"/>
 <result pre="equation-count: ref-count: page-count: word-count: INTRODUCTION Several flaviviruses, such as the" exact="yellow fever" post="virus (YFV), Japanese encephalitis virus (JEV), dengue virus (DENV),"/>
 <result pre="Several flaviviruses, such as the yellow fever virus (YFV), Japanese" exact="encephalitis" post="virus (JEV), dengue virus (DENV), Zika virus (ZIKV), West"/>
 <result pre="virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and" exact="tick-borne encephalitis" post="virus, are important human pathogens. Flaviviruses are spread worldwide,"/>
 <result pre="(DENV), Zika virus (ZIKV), West Nile virus (WNV), and tick-borne" exact="encephalitis" post="virus, are important human pathogens. Flaviviruses are spread worldwide,"/>
 <result pre="in Africa (4). Yellow fever (YF) is an acute viral" exact="hemorrhagic disease" post="which is currently endemic to ∼50 countries with ∼1"/>
 <result pre="in mice and nonhuman primates (17–20). For instance, a recombinant" exact="vaccinia virus" post="or replication-deficient adenoviral vectors expressing YFV-17D NS1, NS2a, and"/>
 <result pre="challenge mice and is referred to as YFV-17D. YFV-17D-based Japanese" exact="encephalitis" post="c-LAV Imojev (Chimerivax-JE, JE-CVax) is not available in Europe"/>
 <result pre="aliquoted, and stored at −80°C. Similarly, the live attenuated Japanese" exact="encephalitis" post="virus vaccine JEV SA14-14-2 (GenBank accession no. AF315119.1) was"/>
 <result pre="Sharma S, Neyts J, Dallmeier K. 2020. A chimeric Japanese" exact="encephalitis" post="vaccine protects against lethal yellow fever virus infection without"/>
 <result pre="K. 2020. A chimeric Japanese encephalitis vaccine protects against lethal" exact="yellow fever" post="virus infection without inducing neutralizing antibodies. mBio 11:e02494-19. https://doi.org/10.1128/mBio.02494-19."/>
 <result pre="J Med374:1552–1563. doi:10.1056/NEJMra1602113.27028561 3.Wilder-SmithA, MonathTP2017Responding to the threat of urban" exact="yellow fever" post="outbreaks. Lancet Infect Dis17:248–250. doi:10.1016/S1473-3099(16)30588-6.28017560 4.Simon-LoriereE, FayeO, ProtM, CasademontI,"/>
 <result pre="CasademontI, FallG, Fernandez-GarciaMD, DiagneMM, KipelaJM, FallIS, HolmesEC, SakuntabhaiA, SallAA2017Autochthonous Japanese" exact="encephalitis" post="with yellow fever coinfection in Africa. N Engl J"/>
 <result pre="Fernandez-GarciaMD, DiagneMM, KipelaJM, FallIS, HolmesEC, SakuntabhaiA, SallAA2017Autochthonous Japanese encephalitis with" exact="yellow fever" post="coinfection in Africa. N Engl J Med376:1483–1485. doi:10.1056/NEJMc1701600.28402771 5.collab:"/>
 <result pre="doi:10.1056/NEJMp1606997.27276108 7.GershmanMD, AngeloKM, RitcheyJ, GreenbergDP, MuhammadRD, BrunetteG, CetronMS, SotirMJ2017Addressing a" exact="yellow fever" post="vaccine shortage—United States, 2016-2017. MMWR Morb Mortal Wkly Rep66:457–459."/>
 <result pre="ChenL, WangS, PangX, LiangM, MaX, LiX, WangQ, ZhangF, LiD2016A fatal" exact="yellow fever" post="virus infection in China: description and lessons. Emerg Microbes"/>
 <result pre="ZhouJH, XiongYQ, DingH, ChenQ2014Immunogenicity and safety of currently available Japanese" exact="encephalitis" post="vaccines: a systematic review. Hum Vaccin Immunother10:3579–3593. doi:10.4161/21645515.2014.980197.25668666 11.MonathTP,"/>
 <result pre="Safety Working Group (V3SWG). 2015Live virus vaccines based on a" exact="yellow fever" post="vaccine backbone: standardized template with key considerations for a"/>
 <result pre="16.WatsonAM, LamLK, KlimstraWB, RymanKD2016The 17D-204 vaccine strain-induced protection against virulent" exact="yellow fever" post="virus is mediated by humoral immunity and CD4+ but"/>
 <result pre="T cells. PLoS Pathog12:e1005786. doi:10.1371/journal.ppat.1005786.27463517 17.PutnakJR, SchlesingerJJ1990Protection of mice against" exact="yellow fever" post="virus encephalitis by immunization with a vaccinia virus recombinant"/>
 <result pre="Pathog12:e1005786. doi:10.1371/journal.ppat.1005786.27463517 17.PutnakJR, SchlesingerJJ1990Protection of mice against yellow fever virus" exact="encephalitis" post="by immunization with a vaccinia virus recombinant encoding the"/>
 <result pre="mice against yellow fever virus encephalitis by immunization with a" exact="vaccinia virus" post="recombinant encoding the yellow fever virus non-structural proteins, NS1,"/>
 <result pre="encephalitis by immunization with a vaccinia virus recombinant encoding the" exact="yellow fever" post="virus non-structural proteins, NS1, NS2a and NS2b. J Gen"/>
 <result pre="Virol71:1697–1702. doi:10.1099/0022-1317-71-8-1697.2144016 18.SchlesingerJJ, FoltzerM, ChapmanS1993The Fc portion of antibody to" exact="yellow fever" post="virus NS1 is a determinant of protection against YF"/>
 <result pre="fever virus NS1 is a determinant of protection against YF" exact="encephalitis" post="in mice. Virology192:132–141. doi:10.1006/viro.1993.1015.8517015 19.SchlesingerJJ, BrandrissMW, CroppCB, MonathTP1986Protection against"/>
 <result pre="encephalitis in mice. Virology192:132–141. doi:10.1006/viro.1993.1015.8517015 19.SchlesingerJJ, BrandrissMW, CroppCB, MonathTP1986Protection against" exact="yellow fever" post="in monkeys by immunization with yellow fever virus nonstructural"/>
 <result pre="CroppCB, MonathTP1986Protection against yellow fever in monkeys by immunization with" exact="yellow fever" post="virus nonstructural protein NS1. J Virol60:1153–1155. doi:10.1128/JVI.60.3.1153-1155.1986.3783816 20.RastogiM, SharmaN,"/>
 <result pre="deficient adenovectors encoding YF-17D antigens induces long-lasting protection from severe" exact="yellow fever" post="virus infection in mice. PLoS Negl Trop Dis10:e0004464. doi:10.1371/journal.pntd.0004464.26886513"/>
 <result pre="Negl Trop Dis10:e0004464. doi:10.1371/journal.pntd.0004464.26886513 24.DesprèsP, DietrichJ, GirardM, BouloyM1991Recombinant baculoviruses expressing" exact="yellow fever" post="virus E and NS1 proteins elicit protective immunity in"/>
 <result pre="GaoN, FanD, ChenH, ShengZ, FuS, LiangG, AnJ2016Cross-protection induced by Japanese" exact="encephalitis" post="vaccines against different genotypes of dengue viruses in mice."/>
 <result pre="BrandrissMW, MonathTP1983Monoclonal antibodies distinguish between wild and vaccine strains of" exact="yellow fever" post="virus by neutralization, hemagglutination inhibition, and immune precipitation of"/>
 <result pre="GargS, AltmanJD, Del RioC, KeyserlingHL, PlossA, RiceCM, OrensteinWA, MulliganMJ, AhmedR2009The" exact="yellow fever" post="virus vaccine induces a broad and polyfunctional human memory"/>
 <result pre="LiYH, QinED, ShiPY, QinCF2013A chimeric dengue virus vaccine using Japanese" exact="encephalitis" post="virus vaccine strain SA14-14-2 as backbone is immunogenic and"/>
 <result pre="BuusS, ChristensenJP, ThomsenAR2015CD8+ T cells complement antibodies in protecting against" exact="yellow fever" post="virus. J Immunol194:1141–1153. doi:10.4049/jimmunol.1402605.25539816 33.CalvertAE, DixonKL, DeloreyMJ, BlairCD, RoehrigJT2014Development"/>
 <result pre="RoehrigJT2014Development of a small animal peripheral challenge model of Japanese" exact="encephalitis" post="virus using interferon deficient AG129 mice and the SA14-14-2"/>
 <result pre="LissNM, PiperJ, BlairCD, RoehrigJT2012A small animal peripheral challenge model of" exact="yellow fever" post="using interferon-receptor deficient mice and the 17D-204 vaccine strain."/>
 <result pre="KlimstraWB, RymanKD2009A mouse model for studying viscerotropic disease caused by" exact="yellow fever" post="virus infection. PLoS Pathog5:e1000614. doi:10.1371/journal.ppat.1000614.19816561 36.YangJ, YangH, LiZ, LinH,"/>
 <result pre="Kanesa-ThasanN, FeroldiE, ReidM2010Concomitant or sequential administration of live attenuated Japanese" exact="encephalitis" post="chimeric virus vaccine and yellow fever 17D vaccine: randomized"/>
 <result pre="administration of live attenuated Japanese encephalitis chimeric virus vaccine and" exact="yellow fever" post="17D vaccine: randomized double-blind phase II evaluation of safety"/>
 <result pre="and immunogenicity. Hum Vaccin6:906–914. doi:10.4161/hv.6.11.12854.20864814 40.ChambersTJ, NestorowiczA, MasonPW, RiceCM1999Yellow fever/Japanese" exact="encephalitis" post="chimeric viruses: construction and biological properties. J Virol73:3095–3101. doi:10.1128/JVI.73.4.3095-3101.1999.10074160"/>
 <result pre="live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese" exact="encephalitis" post="(SA14-14-2) virus and the capsid and nonstructural genes of"/>
 <result pre="encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of" exact="yellow fever" post="(17D) virus is safe, immunogenic and protective in non-human"/>
 <result pre="J Virol80:9557–9568. doi:10.1128/JVI.00080-06.16973559 43.SchlesingerJJ, BrandrissMW, PutnakJR, WalshEE1990Cell surface expression of" exact="yellow fever" post="virus non-structural glycoprotein NS1: consequences of interaction with antibody."/>
 <result pre="non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural" exact="yellow fever" post="virus proteins confer immunity in mice. J Gen Virol67:591–595."/>
 <result pre="OelkeM, SchneckJP, SidneyJ, SetteA, MontenegroSML, MarquesETA2013T-cell memory responses elicited by" exact="yellow fever" post="vaccine are targeted to overlapping epitopes containing multiple HLA-I"/>
 <result pre="SandbergJK2013Temporal dynamics of the primary human T cell response to" exact="yellow fever" post="virus 17D as it matures from an effector- to"/>
 <result pre="ChristensenJP, ThomsenAR, BuusS, StryhnA2017Adaptive immune responses to booster vaccination against" exact="yellow fever" post="virus are much reduced compared to those after primary"/>
 <result pre="Rep7:1–14. doi:10.1038/s41598-017-00798-1.28127051 52.BarrettAD, GouldEA1986Comparison of neurovirulence of different strains of" exact="yellow fever" post="virus in mice. J Gen Virol67:631–637. doi:10.1099/0022-1317-67-4-631.3958694 53.PerelyginAA, ScherbikSV,"/>
 <result pre="Acad Sci U S A99:9322–9327. doi:10.1073/pnas.142287799.12080145 54.TheilerM, SmithHH1937The use of" exact="yellow fever" post="virus modified by in vitro cultivation for human immunization."/>
 <result pre="FeroldiE2010Safety and immunogenicity of a single administration of live-attenuated Japanese" exact="encephalitis" post="vaccine in previously primed 2- to 5-year-olds and naive"/>
 <result pre="WoodwardS, McCarthyK, MathisD, JohnsonC, BedfordP2003Chimeric live, attenuated vaccine against Japanese" exact="encephalitis" post="(ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity,"/>
 <result pre="and schedule, and memory response to challenge with inactivated Japanese" exact="encephalitis" post="antigen. J Infect Dis188:1213–1230. doi:10.1086/378356.14551893 57.GuirakhooF, KitchenerS, MorrisonD, ForratR,"/>
 <result pre="YoksanS, DuanX, ErmakTH, Kanesa-ThasanN, BedfordP, LangJ, Quentin-MilletMJ, MonathTP2006Live attenuated chimeric" exact="yellow fever" post="dengue type 2 (ChimeriVax-DEN2) vaccine: phase I clinical trial"/>
 <result pre="phase I clinical trial for safety and immunogenicity: effect of" exact="yellow fever" post="pre-immunity in induction of cross neutralizing antibody responses to"/>
 <result pre="ZhangZX, MonathTP, ChambersTJ2001Molecular basis for attenuation of neurovirulence of a" exact="yellow fever" post="Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE). J Virol75:934–942. doi:10.1128/JVI.75.2.934-942.2001.11134306"/>
 <result pre="basis for attenuation of neurovirulence of a yellow fever Virus/Japanese" exact="encephalitis" post="virus chimera vaccine (ChimeriVax-JE). J Virol75:934–942. doi:10.1128/JVI.75.2.934-942.2001.11134306 60.ZmurkoJ, MarquesRE,"/>
 <result pre="Dis10:e0004695. doi:10.1371/journal.pntd.0004695.27163257 61.BredenbeekPJ, KooiEA, LindenbachB, HuijkmanN, RiceCM, SpaanWJ2003A stable full-length" exact="yellow fever" post="virus cDNA clone and the role of conserved RNA"/>
 <result pre="NS1. J Exp Med207:793–806. doi:10.1084/jem.20092545.20308361 64.Barba-SpaethG, LongmanRS, AlbertML, RiceCM2005Live attenuated" exact="yellow fever" post="17D infects human DCs and allows for presentation of"/>
 <result pre="infected with YFV-17D. J Gen Virol96:1328–1339. doi:10.1099/vir.0.000075.25646269 72.JulanderJG2016Animal models of" exact="yellow fever" post="and their application in clinical research. Curr Opin Virol18:64–69."/>
 <result pre="exerts a critical early restriction on replication and dissemination of" exact="yellow fever" post="virus vaccine strain 17D-204. NPJ Vaccines3:5. doi:10.1038/s41541-017-0039-z.29387474 74.HuangS, HendriksW,"/>
 <result pre="76.JohnsonBW, KosoyO, HunspergerE, BeltranM, DeloreyM, GuirakhooF, MonathT2009Evaluation of chimeric Japanese" exact="encephalitis" post="and dengue viruses for use in diagnostic plaque reduction"/>
 <result pre="Microbiol53:557–566. doi:10.1128/JCM.02735-14.25502522 81.FalgoutB, BrayM, SchlesingerJJ, LaiCJ1990Immunization of mice with recombinant" exact="vaccinia virus" post="expressing authentic dengue virus nonstructural protein NS1 protects against"/>
</results>
